Impact of MYC-R on the outcome of LS DLBCL patients

Vera De Jonge, PhD student from the VUMC, Amsterdam and Johanna Bult, PhD student from the University Medical Center Groningen assessed the impact of a rearrangement of the MYC oncogene on the outcome of patients with stage I or II diffuse large B-cell lymphoma in the Netherlands. 

With the educational support of: